Modern Diagnostic and Research Centre's IPO is seeing strong investor interest, with the issue subscribed over 15 times by midday on its second day. The grey market premium (GMP) indicates a potential listing gain of around 14 percent. The company aims to raise Rs 37 crore by issuing fresh shares at Rs 85-90 each. Proceeds will fund medical equipment, working capital, and debt repayment.